Myeloma criteria

Guidelines: Multiple Myeloma General: 2025: International Myeloma Working Group PMID Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. (International Myeloma Working Group [no authors listed], Br J Haematol. 2025

Revised IMWG Diagnostic Criteria for Multiple Myeloma and Smouldering Multiple Myeloma. Definition of multiple myeloma. Clonal bone marrow plasma cells ‰ 10 percent or biopsy-proven bony or extramedullary plasmacytoma and any one

Latent Multiple Myeloma (SMM) Both criteria must be met: Serum monoclonal protein (IgG or IgA) 3 g/dl, or monoclonal urinary protein 500 mg in 24 hours and/or 10%-60% of clonal plasma cells in the bone marrow; Absence of events defining myeloma or amyloidosis. Multiple Myeloma (MM) Both criteria must be met:

International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2025; .

The Italian myeloma criteria for PET use (IMPeTUs) were proposed to standardize FDG PET/CT reading in multiple myeloma. In this communication an overview on IMPeTUs is provided as well as some

For patients with precursor disease to multiple myeloma (MM), the standard for predicting disease progression is the risk stratification criteria from the International Myeloma Working Group (IMWG). These criteria put patients into one of four risk groups – low, low-intermediate, high-intermediate, or high – based on information

The revised International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma and related disorders are shown on Table 1.1 The diagnosis of multiple myeloma

The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma and have considerable impact on the management of the disease. For decades the diagnosis of multiple myeloma required the presence of end-organ damage known as the CRAB criteria, including increased calcium level, renal dysfunction, anemia

Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol 2024;6 35 Search PubMed; The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.